Laboratory Corporation of America Holdings (0JSY.L)
USD 225.47
(2.86%)
USD 225.47
(2.86%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 12.16 Billion USD | -18.25% |
| 2022 | 14.87 Billion USD | -7.72% |
| 2021 | 16.12 Billion USD | 15.33% |
| 2020 | 13.97 Billion USD | 20.98% |
| 2019 | 11.55 Billion USD | 1.95% |
| 2018 | 11.33 Billion USD | 8.54% |
| 2017 | 10.44 Billion USD | 8.29% |
| 2016 | 9.64 Billion USD | 11.08% |
| 2015 | 8.68 Billion USD | 44.39% |
| 2014 | 6.01 Billion USD | 3.5% |
| 2013 | 5.8 Billion USD | 2.41% |
| 2012 | 5.67 Billion USD | 2.33% |
| 2011 | 5.54 Billion USD | 10.76% |
| 2010 | 5 Billion USD | 6.59% |
| 2009 | 4.69 Billion USD | 4.21% |
| 2008 | 4.5 Billion USD | 10.74% |
| 2007 | 4.06 Billion USD | 13.3% |
| 2006 | 3.59 Billion USD | 7.91% |
| 2005 | 3.32 Billion USD | 7.87% |
| 2004 | 3.08 Billion USD | 4.95% |
| 2003 | 2.93 Billion USD | 17.21% |
| 2002 | 2.5 Billion USD | 14.0% |
| 2001 | 2.19 Billion USD | 14.61% |
| 2000 | 1.91 Billion USD | 12.99% |
| 1999 | 1.69 Billion USD | 5.34% |
| 1998 | 1.61 Billion USD | 6.16% |
| 1997 | 1.51 Billion USD | -5.52% |
| 1996 | 1.6 Billion USD | 12.27% |
| 1995 | 1.43 Billion USD | 64.13% |
| 1994 | 872.5 Million USD | 14.73% |
| 1993 | 760.5 Million USD | 5.42% |
| 1992 | 721.4 Million USD | 19.46% |
| 1991 | 603.9 Million USD | 20.32% |
| 1990 | 501.9 Million USD | 24.73% |
| 1989 | 402.4 Million USD | 28.19% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 3.22 Billion USD | 1.39% |
| 2024 Q2 | 3.28 Billion USD | 1.9% |
| 2023 Q3 | 3.03 Billion USD | -0.77% |
| 2023 Q2 | 3.05 Billion USD | 0.76% |
| 2023 Q1 | 3.03 Billion USD | -19.7% |
| 2023 Q4 | 3.17 Billion USD | 4.72% |
| 2023 FY | 12.16 Billion USD | -18.25% |
| 2022 FY | 14.87 Billion USD | -7.72% |
| 2022 Q1 | 3.69 Billion USD | -5.2% |
| 2022 Q2 | 3.6 Billion USD | -2.46% |
| 2022 Q3 | 3.67 Billion USD | 1.89% |
| 2022 Q4 | 3.77 Billion USD | 2.82% |
| 2021 Q1 | 3.84 Billion USD | -7.71% |
| 2021 Q2 | 4.06 Billion USD | 5.78% |
| 2021 Q3 | 4.05 Billion USD | -0.16% |
| 2021 Q4 | 3.89 Billion USD | -3.86% |
| 2021 FY | 16.12 Billion USD | 15.33% |
| 2020 FY | 13.97 Billion USD | 20.98% |
| 2020 Q3 | 4.48 Billion USD | 15.24% |
| 2020 Q2 | 3.89 Billion USD | 40.71% |
| 2020 Q4 | 4.16 Billion USD | -7.31% |
| 2020 Q1 | 2.76 Billion USD | -1.95% |
| 2019 Q3 | 2.95 Billion USD | 0.85% |
| 2019 Q4 | 2.82 Billion USD | -4.39% |
| 2019 FY | 11.55 Billion USD | 1.95% |
| 2019 Q1 | 2.88 Billion USD | 3.24% |
| 2019 Q2 | 2.92 Billion USD | 1.62% |
| 2018 Q2 | 2.83 Billion USD | -1.22% |
| 2018 FY | 11.33 Billion USD | 8.54% |
| 2018 Q4 | 2.79 Billion USD | 0.13% |
| 2018 Q3 | 2.78 Billion USD | -1.55% |
| 2018 Q1 | 2.86 Billion USD | 0.63% |
| 2017 Q4 | 2.84 Billion USD | 1.86% |
| 2017 FY | 10.44 Billion USD | 8.29% |
| 2017 Q1 | 2.54 Billion USD | 3.92% |
| 2017 Q3 | 2.79 Billion USD | 5.31% |
| 2017 Q2 | 2.65 Billion USD | 4.42% |
| 2016 FY | 9.64 Billion USD | 11.08% |
| 2016 Q2 | 2.41 Billion USD | -0.66% |
| 2016 Q4 | 2.44 Billion USD | 0.77% |
| 2016 Q3 | 2.42 Billion USD | 0.57% |
| 2016 Q1 | 2.43 Billion USD | 2.65% |
| 2015 Q3 | 2.3 Billion USD | -0.72% |
| 2015 FY | 8.68 Billion USD | 44.39% |
| 2015 Q4 | 2.36 Billion USD | 2.93% |
| 2015 Q1 | 2.26 Billion USD | 26.54% |
| 2015 Q2 | 2.31 Billion USD | 2.12% |
| 2014 Q2 | 1.55 Billion USD | 2.33% |
| 2014 Q1 | 1.51 Billion USD | 5.99% |
| 2014 Q3 | 1.51 Billion USD | -2.52% |
| 2014 FY | 6.01 Billion USD | 3.5% |
| 2014 Q4 | 1.79 Billion USD | 18.54% |
| 2013 Q2 | 1.46 Billion USD | -0.41% |
| 2013 FY | 5.8 Billion USD | 2.41% |
| 2013 Q4 | 1.43 Billion USD | -0.44% |
| 2013 Q1 | 1.46 Billion USD | 1.89% |
| 2013 Q3 | 1.43 Billion USD | -1.72% |
| 2012 Q4 | 1.44 Billion USD | 2.53% |
| 2012 FY | 5.67 Billion USD | 2.33% |
| 2012 Q3 | 1.4 Billion USD | -0.99% |
| 2012 Q2 | 1.41 Billion USD | -0.28% |
| 2012 Q1 | 1.42 Billion USD | 0.01% |
| 2011 Q4 | 1.42 Billion USD | 4.19% |
| 2011 FY | 5.54 Billion USD | 10.76% |
| 2011 Q3 | 1.36 Billion USD | -2.73% |
| 2011 Q1 | 1.4 Billion USD | 2.55% |
| 2011 Q2 | 1.4 Billion USD | 0.09% |
| 2010 Q3 | 1.29 Billion USD | 1.48% |
| 2010 FY | 5 Billion USD | 6.59% |
| 2010 Q4 | 1.36 Billion USD | 5.64% |
| 2010 Q1 | 1.23 Billion USD | 3.75% |
| 2010 Q2 | 1.27 Billion USD | 3.08% |
| 2009 FY | 4.69 Billion USD | 4.21% |
| 2009 Q4 | 1.19 Billion USD | 2.45% |
| 2009 Q3 | 1.16 Billion USD | -1.69% |
| 2009 Q2 | 1.18 Billion USD | -0.31% |
| 2009 Q1 | 1.18 Billion USD | 2.86% |
| 2008 FY | 4.5 Billion USD | 10.74% |
| 2008 Q4 | 1.15 Billion USD | 3.27% |
| 2008 Q1 | 1.14 Billion USD | 4.04% |
| 2008 Q2 | 1.13 Billion USD | -1.11% |
| 2008 Q3 | 1.11 Billion USD | -1.41% |
| 2007 Q3 | 1 Billion USD | -1.45% |
| 2007 FY | 4.06 Billion USD | 13.3% |
| 2007 Q1 | 1.04 Billion USD | 4.45% |
| 2007 Q2 | 1.02 Billion USD | -2.16% |
| 2007 Q4 | 1.1 Billion USD | 9.68% |
| 2006 FY | 3.59 Billion USD | 7.91% |
| 2006 Q4 | 998.7 Million USD | 11.14% |
| 2006 Q3 | 898.6 Million USD | -1.24% |
| 2006 Q2 | 909.9 Million USD | 0.69% |
| 2006 Q1 | 903.7 Million USD | 2.87% |
| 2005 Q3 | 822.3 Million USD | -3.59% |
| 2005 Q2 | 852.9 Million USD | -0.05% |
| 2005 Q4 | 878.5 Million USD | 6.83% |
| 2005 Q1 | 853.3 Million USD | 6.78% |
| 2005 FY | 3.32 Billion USD | 7.87% |
| 2004 Q2 | 781.5 Million USD | -0.36% |
| 2004 FY | 3.08 Billion USD | 4.95% |
| 2004 Q4 | 799.1 Million USD | 4.25% |
| 2004 Q1 | 784.3 Million USD | 4.23% |
| 2004 Q3 | 766.5 Million USD | -1.92% |
| 2003 Q1 | 743.7 Million USD | 4.42% |
| 2003 Q3 | 731.5 Million USD | -2.73% |
| 2003 Q2 | 752 Million USD | 1.12% |
| 2003 FY | 2.93 Billion USD | 17.21% |
| 2003 Q4 | 752.5 Million USD | 2.87% |
| 2002 Q2 | 655.2 Million USD | 6.99% |
| 2002 Q1 | 612.4 Million USD | 3.8% |
| 2002 Q3 | 650.1 Million USD | -0.78% |
| 2002 Q4 | 712.2 Million USD | 9.55% |
| 2002 FY | 2.5 Billion USD | 14.0% |
| 2001 FY | 2.19 Billion USD | 14.61% |
| 2001 Q4 | 590 Million USD | 4.65% |
| 2001 Q3 | 563.8 Million USD | 0.52% |
| 2001 Q1 | 549.7 Million USD | 4.63% |
| 2001 Q2 | 560.9 Million USD | 2.04% |
| 2000 Q4 | 525.4 Million USD | 8.11% |
| 2000 Q1 | 482.4 Million USD | 4.26% |
| 2000 FY | 1.91 Billion USD | 12.99% |
| 2000 Q2 | 488.1 Million USD | 1.18% |
| 2000 Q3 | 486 Million USD | -0.43% |
| 1999 Q2 | 428.6 Million USD | -0.21% |
| 1999 FY | 1.69 Billion USD | 5.34% |
| 1999 Q4 | 462.7 Million USD | 9.46% |
| 1999 Q3 | 422.7 Million USD | -1.38% |
| 1999 Q1 | 429.5 Million USD | 2.78% |
| 1998 Q3 | 455.2 Million USD | 14.29% |
| 1998 Q2 | 398.3 Million USD | 3.16% |
| 1998 Q4 | 417.9 Million USD | -8.19% |
| 1998 Q1 | 386.1 Million USD | 3.51% |
| 1998 FY | 1.61 Billion USD | 6.16% |
| 1997 Q1 | 389.6 Million USD | -0.49% |
| 1997 FY | 1.51 Billion USD | -5.52% |
| 1997 Q4 | 373 Million USD | 3.21% |
| 1997 Q3 | 361.4 Million USD | -4.01% |
| 1997 Q2 | 376.5 Million USD | -3.36% |
| 1996 Q1 | 410 Million USD | 1.51% |
| 1996 FY | 1.6 Billion USD | 12.27% |
| 1996 Q4 | 391.5 Million USD | 0.08% |
| 1996 Q3 | 391.2 Million USD | -2.83% |
| 1996 Q2 | 402.6 Million USD | -1.8% |
| 1995 Q2 | 417.5 Million USD | 13.67% |
| 1995 Q4 | 403.9 Million USD | 0.12% |
| 1995 Q1 | 367.3 Million USD | 50.66% |
| 1995 FY | 1.43 Billion USD | 64.13% |
| 1995 Q3 | 403.4 Million USD | -3.38% |
| 1994 Q4 | 243.8 Million USD | 3.79% |
| 1994 Q2 | 248.7 Million USD | 21.97% |
| 1994 Q1 | 203.9 Million USD | 10.22% |
| 1994 FY | 872.5 Million USD | 14.73% |
| 1994 Q3 | 234.9 Million USD | -5.55% |
| 1993 Q1 | 197 Million USD | -1.4% |
| 1993 Q4 | 185 Million USD | 9.53% |
| 1993 Q3 | 168.9 Million USD | -13.3% |
| 1993 Q2 | 194.8 Million USD | -1.12% |
| 1993 FY | 760.5 Million USD | 5.42% |
| 1992 Q3 | 180.3 Million USD | -1.8% |
| 1992 Q1 | 181.1 Million USD | 2.66% |
| 1992 Q2 | 183.6 Million USD | 1.38% |
| 1992 FY | 721.4 Million USD | 19.46% |
| 1992 Q4 | 199.8 Million USD | 10.82% |
| 1991 Q4 | 176.4 Million USD | 14.32% |
| 1991 FY | 603.9 Million USD | 20.32% |
| 1991 Q2 | 153.6 Million USD | -0.32% |
| 1991 Q3 | 154.3 Million USD | 0.46% |
| 1991 Q1 | 154.1 Million USD | 8.6% |
| 1990 Q4 | 141.9 Million USD | 12.26% |
| 1990 Q2 | 126 Million USD | -1.1% |
| 1990 FY | 501.9 Million USD | 24.73% |
| 1990 Q1 | 127.4 Million USD | 4.34% |
| 1990 Q3 | 126.4 Million USD | 0.32% |
| 1989 Q3 | 107.7 Million USD | 6.74% |
| 1989 FY | 402.4 Million USD | 28.19% |
| 1989 Q4 | 122.1 Million USD | 13.37% |
| 1989 Q1 | 99.9 Million USD | 6.39% |
| 1989 Q2 | 100.9 Million USD | 1.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -3313.313% |
| Accuray Incorporated | 446.55 Million USD | -2623.452% |
| Align Technology, Inc. | 3.86 Billion USD | -214.883% |
| Elevance Health Inc. | 171.34 Billion USD | 92.902% |
| AxoGen, Inc. | 159.01 Million USD | -7548.228% |
| Boston Scientific Corporation | 14.24 Billion USD | 14.596% |
| CVS Health Corporation | 357.77 Billion USD | 96.601% |
| Cardinal Health, Inc. | 226.82 Billion USD | 94.638% |
| Centene Corporation | 141.26 Billion USD | 91.391% |
| DaVita Inc. | 12.14 Billion USD | -0.177% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 81.281% |
| Hologic, Inc. | 4.03 Billion USD | -201.754% |
| Humana Inc. | 106.37 Billion USD | 88.567% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -232.198% |
| Masimo Corporation | 2.04 Billion USD | -493.799% |
| McKesson Corporation | 308.95 Billion USD | 96.064% |
| Patterson Companies, Inc. | 6.56 Billion USD | -85.157% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | -31.448% |
| ResMed Inc. | 4.68 Billion USD | -159.569% |
| Henry Schein, Inc. | 12.33 Billion USD | 1.438% |
| Teladoc Health, Inc. | 2.6 Billion USD | -367.32% |
| Universal Health Services, Inc. | 14.28 Billion USD | 14.847% |
| Veeva Systems Inc. | 2.36 Billion USD | -414.521% |
| Baxter International Inc. | 14.81 Billion USD | 17.899% |
| Becton, Dickinson and Company | 19.37 Billion USD | 37.221% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | -70.711% |
| Danaher Corporation | 23.89 Billion USD | 49.093% |
| Stryker Corporation | 20.49 Billion USD | 40.669% |
| Medtronic plc | 32.36 Billion USD | 62.422% |